JOINN Laboratories reports nine-month revenue growth of 20.60%
Regulatory / securities filing · 昭衍新药 / 巨潮资讯 CNinfo
Source published: · Event / reporting date: 2026-09-30
Site published: 2026-11-03 · Updated: 2026-11-03
This source is linked automatically. Choose a question to get started.
What changed
JOINN Laboratories reported consolidated revenue of RMB1.188 billion, up 20.60%, and attributable net income of RMB929.7 million for the nine months ended September 30, 2026. Biological-asset fair-value changes contributed approximately RMB866.3 million in net gains, materially affecting reported earnings. The quarterly filing is unaudited and covers the year-to-date period.
Why it may matter
Even earnings excluding nonrecurring items include biological-asset revaluation, making service contributions and orders more informative for operating comparisons.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections